256 The TIGIT/CD226/CD155 axis and the effects of combining PD-1/PD-L1 blockade with TIGIT-targeting antibody therapy in syngeneic murine glioblastoma models
暂无分享,去创建一个
G. Freeman | P. Gokhale | A. Anderson | B. Eschle | Michael J. Poitras | D. Reardon | B. Iorgulescu | M. Klapholz